Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-02-14
4:14 pm
Sale
13GAevi Genomic Medicine LLC
GNMX
BAKER BROS. ADVISORS LP564,844
0.7%
-3,385,575decrease
(-85.70%)
View
2020-02-12
4:28 pm
Sale
13GAevi Genomic Medicine LLC
GNMX
ADAGE CAPITAL PARTNERS GP L.L.C.423,633
0.54%
-5,076,367decrease
(-92.30%)
View
2020-02-07
12:56 pm
Purchase
13DAevi Genomic Medicine LLC
GNMX
ASTRAZENECA PLC12,946,900
16.7%
12,946,900increase
(New Position)
View
2020-01-06
4:06 pm
Purchase
13DAevi Genomic Medicine LLC
GNMX
Children's Hospital of Philadelphia Foundation57,280,927
49.1%
6,473,450increase
(+12.74%)
View
2019-12-06
5:18 pm
Purchase
13DAevi Genomic Medicine LLC
GNMX
Children's Hospital of Philadelphia Foundation50,807,477
52.3%
4,661,074increase
(+10.10%)
View
2019-11-20
4:30 pm
Purchase
13DAevi Genomic Medicine LLC
GNMX
Children's Hospital of Philadelphia Foundation46,146,403
47.5%
24,834,817increase
(+116.53%)
View
2019-10-22
4:59 pm
Unchanged
13DAevi Genomic Medicine LLC
GNMX
Children's Hospital of Philadelphia Foundation21,311,586
31.5%
0
(Unchanged)
View
2019-03-29
5:27 pm
Purchase
13DAevi Genomic Medicine LLC
GNMX
Children's Hospital of Philadelphia Foundation21,311,586
31.5%
63,333increase
(+0.30%)
View
2019-02-13
4:29 pm
Sale
13GAevi Genomic Medicine LLC
GNMX
BAKER BROS. ADVISORS LP3,950,419
6.1%
-104,723decrease
(-2.58%)
View